Company Analysis

Oric Pharmaceuticals, Inc. (ORIC)

Nasdaq: ORIC · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2019
Grade5.3
◀ Past 5.5● Present 6.1▶ Future 4.3
6 est.

Who runs Oric Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Chacko Jacob
PRESIDENT AND CEO. First filing Apr 2020, latest Jan 6, 2026, 24 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
13 people on the record since 2020
Officerssales are open-market, Oct 21, 2025 to Oct 21, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Piscitelli DominicChief Financial OfficerApr 2020Oct 21, 20267 · $2.2M
Chacko JacobPRESIDENT AND CEOApr 2020Jan 6, 20261 · $300,000
Multani Pratik SChief Medical OfficerApr 2020Jan 6, 20261 · $100,000
Directorssales are open-market, Oct 21, 2025 to Oct 21, 2026
NameRoleFirst filingLatest filingSales, 12 months
Heyman Richard A.directorApr 2020Oct 2, 20267 · $300,000
Dier MardidirectorApr 2020Jan 6, 2026none
Hoerter Steven L.directorAug 2021Jan 6, 2026none
Kunkel Lori AnnedirectorJun 2020Jan 6, 2026none
You AngiedirectorNov 2021Jan 6, 2026none
Earlier names on the record14, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ORIC · research, not advice